Stocks · News reference
Filed: 2026-11-02 AccNo: 0001627223-26-000032 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
The Chemours Company has introduced its Faizeon portfolio of dielectric fluids designed for two-phase direct-to-chip and immersion cooling in AI and high-performance computing data centers.
Barclays has reaffirmed its 'Hold' rating and $16 price target for The Chemours Company.
Chemours (NYSE:CC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
The Chemours Company is conducting its third-quarter 2026 earnings call to discuss financial results and provide management commentary.
A class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly overstating market demand for its Opteon products and providing unreliable financial guidance. The company reduced its full-year adjusted EBITDA guidance in August 2026, causing the stock to drop 18.63%. Investors who purchased CC securities between February 20, 2026 and August 4, 2026 may be eligible to participate in the lawsuit.
Core Silver Corp. announced an update on drill holes TL-26-010 to 015 from the phase one drilling program at its Touleary Project in Yukon, Canada.